Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica

Brain

Volumn 124, Issue 3, 2001, Pages 493-498

  Mandler, Raul N ^a,c   Dencoff, John D ^a   Midani, Fatma ^a,d   Ford, Corey C ^a   Ahmed, Waseem ^a,e   Rosenberg, Gary A ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Devic's neuromyelitis optica; Gelatinase B; Matrix metalloproteinases; Multiple sclerosis; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE A; IMMUNOGLOBULIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMAGING; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; ZYMOGRAPHY;

EID: 0035100551     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.3.493     Document Type: Article

References (29)

1. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
2. Matrix metalloproteinases: A review
3. Protease production by cultured microglia: Substrate gel analysis and immobilized matrix degradation
4. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
5. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
6. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons
7. Proteolysis and myelin breakdown: A review of recent histochemical and biochemical studies
8. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium
9. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors
10. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
11. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase
12. Quantitative zymography: Detection of picogram quantities of gelatinases
13. T cell gelatinases mediate basement membrane transmigration in vitro
14. Devic's neuromyelitis optica: A clinicopathological study of 8 patients
15. Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine
16. Matrix metalloproteinases in cerebrovascular disease
17. Quantitative reverse zymography: Analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms
18. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
19. Devic's neuromyelitis optica: Long-term follow-up and serial CSF findings in two cases
20. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
21. Esterase, peptidase and proteinase activities of human cerebrospinal fluid in multiple sclerosis
22. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
23. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window
24. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury
25. Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis
26. Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS
27. Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
28. The clinical course of neuromyelitis optica (Devic's syndrome)
29. Matrix metalloproteinases and diseases of the CNS